Evidence map›Paper›PMID 33822029›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2021

The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences.

Monika Gawałko, David Duncker, Martin Manninger, Rachel M J van der Velden, Astrid N L Hermans, Dominique V M Verhaert, Laurent Pison, Ron Pisters, Martin Hemels, Arian Sultan and 24 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Initial experience with a virtual atrial fibrillation clinic after pulmonary vein isolation using follow-up with photoplethysmography.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Everyone over the age of 65 years should wear a smartwatch : Pro and contra].Herzschrittmachertherapie & Elektrophysiologie · 2024
    Review
  17. Smartphone app-based approximation of time spent with atrial fibrillation and symptoms in patients after catheter ablation: data from the TeleCheck-AF project.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 10 countries.

Monika GawałkoDepartment of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, 6202 AZ Maastricht, The Netherlands.ORCID 0000-0003-4619-9062
David DunckerDepartment of Cardiology and Angiology, Hannover Heart Rhythm Center, Hannover Medical School, Hannover, Germany.
Martin ManningerDivision of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Rachel M J van der VeldenDepartment of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, 6202 AZ Maastricht, The Netherlands.
Astrid N L HermansDepartment of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, 6202 AZ Maastricht, The Netherlands.
Dominique V M VerhaertDepartment of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Laurent PisonZienkenhuis Oost Limburg, Genk, Belgium.
Ron PistersDepartment of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
Martin HemelsDepartment of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
Arian SultanDepartment of Electrophysiology, University of Cologne, Heart Centre, Cologne, Germany.
Daniel StevenDepartment of Electrophysiology, University of Cologne, Heart Centre, Cologne, Germany.
Dhiraj GuptaDepartment of Cardiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Hein HeidbuchelAntwerp University and University Hospital, Antwerp, Belgium.
Afzal SohaibBarts Heart Centre, West Smithfield, London, UK.
Petra WijtvlietDepartment of Cardiology, Martini Hospital, Groningen, The Netherlands.
Robert TielemanDepartment of Cardiology, Martini Hospital, Groningen, The Netherlands.
Henri GruwezUniversity of Leuven, Leuven, Belgium.
Julian ChunCardioangiologisches Centrum Bethanien, Frankfurt, Germany.
Boris SchmidtCardioangiologisches Centrum Bethanien, Frankfurt, Germany.
John J KeaneyMater Misericordiae University Hospital, Dublin, Ireland.
Patrick MüllerDepartment of Cardiology II-Electrophysiology, University Hospital of Münster, Münster, Germany.
Piotr Lodziński1st Department of Cardiology, Doctoral School, Medical University of Warsaw, Warsaw, Poland.
Emma SvennbergDepartment of Clinical Sciences, Karolinska Institutet, Danderyd's University Hospital, Stockholm, Sweden.
Olga HoekstraTergooi Hospital, Hilversum, The Netherlands.
Ward P J JansenTergooi Hospital, Hilversum, The Netherlands.
Lien DestegheAntwerp University Hospital and Antwerp University, Antwerp, Belgium.
Tom de PotterCardiovascular Center, Onze Lieve Vrouwziekenhuis, Aalst, Belgium.
David R TomlinsonDerriford Hospital, Plymouth, UK.
Lis NeubeckSchool of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.
Harry J G M CrijnsDepartment of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, 6202 AZ Maastricht, The Netherlands.
Nikki A H A PluymaekersDepartment of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, 6202 AZ Maastricht, The Netherlands.
Jeroen M HendriksCentre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
Dominik LinzDepartment of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, 6202 AZ Maastricht, The Netherlands.
TeleCheck-AF investigators
Maastricht University Medical Centre · NLCardiovascular Center Bethanien · DEMartini Ziekenhuis · NLMedical University of Warsaw · PLRijnstate Hospital · NLTergooi · NLUniversity of Cologne · DEAntwerp University Hospital · BEBritish Heart Foundation · GBDerriford Hospital · GBEdinburgh Napier University · GBJessa Hospital · BEKarolinska University Hospital · SEKU Leuven · BEMater Misericordiae University Hospital · IEMedical University of Graz · ATMedizinische Hochschule Hannover · DEOnze Lieve Vrouwziekenhuis Hospital · BERadboud University Nijmegen · NLRoyal Adelaide Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTeleCheck-AF is a multicentre international project initiated to maintain care delivery for patients with atrial fibrillation (AF) during COVID-19 through teleconsultations supported by an on-demand photoplethysmography-based heart rate and rhythm monitoring app (FibriCheck®). We describe the characteristics, inclusion rates, and experiences from participating centres according the TeleCheck-AF infrastructure as well as characteristics and experiences from recruited patients. METHODS AND

resultsThree surveys exploring centre characteristics (n = 25), centre experiences (n = 23), and patient experiences (n = 826) were completed. Self-reported patient characteristics were obtained from the app. Most centres were academic (64%) and specialized public cardiology/district hospitals (36%). Majority of the centres had AF outpatient clinics (64%) and only 36% had AF ablation clinics. The time required to start patient inclusion and total number of included patients in the project was comparable for centres experienced (56%) or inexperienced in mHealth use. Within 28 weeks, 1930 AF patients were recruited, mainly for remote AF control (31% of patients) and AF ablation follow-up (42%). Average inclusion rate was highest during the lockdown restrictions and reached a steady state at a lower level after easing the restrictions (188 vs. 52 weekly recruited patients). Majority (>80%) of the centres reported no problems during the implementation of the TeleCheck-AF approach. Recruited patients [median age 64 (55-71), 62% male] agreed that the FibriCheck® app was easy to use (94%).

conclusionDespite different health care settings and mobile health experiences, the TeleCheck-AF approach could be set up within an extremely short time and easily used in different European centres during COVID-19.

Indexed as

Atrial FibrillationCOVID-19Mobile ApplicationsCommunicable Disease ControlFemaleHumansMaleMiddle AgedPandemicsPatient Outcome AssessmentSARS-CoV-2Atrial fibrillationCOVID-19eHealthmHealthRemote monitoringTeleCheck-AFTelemedicine

Identifiers

PMID33822029
PMCPMC8083545
OpenAlexW3149244439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.